Press Releases

Press Releases

SAN DIEGO , Dec. 01, 2020 (GLOBE NEWSWIRE) -- Travere Therapeutics (NASDAQ: TVTX) today announced that the Company will host a virtual R&D Day on Wednesday, December 9, 2020 at 12:00 p.m. ET to review the Company’s key pipeline programs. The event will feature presentations from external experts
Dec 01, 2020
New name reflects dedication to patient- inspired mission of identifying, developing and delivering life-changing rare disease therapies In Rare for Life Company’s s hares to t rade u nder n ew t icker s ymbol TVTX on November 19 SAN DIEGO , Nov. 16, 2020 (GLOBE NEWSWIRE) -- Retrophin Inc.
Nov 16, 2020
Addition of OT-58 strengthens pipeline of potential first-in-class therapies targeting rare diseases SAN DIEGO , Nov. 12, 2020 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX) today announced the completion of its previously announced acquisition of Orphan Technologies Limited , a privately held,
Nov 12, 2020
SAN DIEGO , Nov. 11, 2020 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX) today announced that Company management will present at the following upcoming virtual investor conferences in November and December: Jefferies 20 20   Virtual London Healthcare Conference Date: Wednesday, November 18,
Nov 11, 2020
Pivotal DUPLEX Study of sparsentan in FSGS nears completion of enrollment; topline proteinuria data expected 1Q21 Pivotal PROTECT Study achieved enrollment of 280 th patient with IgAN to enable topline proteinuria data in 3Q21 Expanding pipeline of potential first-in-class therapies with agreement
Nov 05, 2020
Agreement a dd s OT-58, a novel enzyme replacement therapy in Phase 1/2 development for the treatment of classical homocystinuria Compelling strategic fit that will expand p ipeline of potential first-in-class therapies targeting rare diseases Retrophin to host conference call and webcast today at
Oct 22, 2020
SAN DIEGO , Oct. 21, 2020 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX) today announced it will report third quarter 2020 financial results on Thursday, November 5, 2020 after the close of the U.S. financial markets. The Company will host a conference call and webcast to discuss the financial
Oct 21, 2020
SAN DIEGO , Oct. 14, 2020 (GLOBE NEWSWIRE) -- Retrophin, Inc. (Nasdaq: RTRX) today announced that on October 10, 2020 , the Compensation Committee of its Board of Directors granted inducement equity grants covering an aggregate of 58,750 shares of its common stock to four new employees, consisting
Oct 14, 2020